Cargando…

Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden

BACKGROUND: The population of adults with congenital heart disease (CHD) is growing, and increasingly more patients with CHD reach older ages. Patients with CHD are at an increased risk of myocardial infarction (MI) with increased age. Diagnosing MI in patients with CHD can be challenging in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Fedchenko, Maria, Mandalenakis, Zacharias, Hultsberg-Olsson, Görel, Dellborg, Helena, Eriksson, Peter, Dellborg, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584083/
https://www.ncbi.nlm.nih.gov/pubmed/33096985
http://dx.doi.org/10.1186/s12872-020-01737-1
_version_ 1783599526852952064
author Fedchenko, Maria
Mandalenakis, Zacharias
Hultsberg-Olsson, Görel
Dellborg, Helena
Eriksson, Peter
Dellborg, Mikael
author_facet Fedchenko, Maria
Mandalenakis, Zacharias
Hultsberg-Olsson, Görel
Dellborg, Helena
Eriksson, Peter
Dellborg, Mikael
author_sort Fedchenko, Maria
collection PubMed
description BACKGROUND: The population of adults with congenital heart disease (CHD) is growing, and increasingly more patients with CHD reach older ages. Patients with CHD are at an increased risk of myocardial infarction (MI) with increased age. Diagnosing MI in patients with CHD can be challenging in clinical practice owing to a high prevalence of aberrant electrocardiograms, ventricular hypertrophy, and heart failure, among other factors. The National Swedish Patient Register (NPR) is widely used in epidemiological studies; however, MI diagnoses specifically in patients with CHD have never been validated in the NPR. METHODS: We contacted hospitals and medical archive services to request medical records for 249 patients, born during 1970–2012, with both CHD and MI diagnoses and who were randomly selected from the NPR by the Swedish National Board of Health and Welfare. Follow-up was until 2015. We performed a medical chart review to validate the MI diagnoses; we also validated CHD diagnoses to ensure that only patients with confirmed CHD diagnoses were included in the MI validation process. RESULTS: We received medical records for 96.4% (n = 238/249) of patients for validation of CHD diagnoses. In total, 74.8% (n = 178/238) had a confirmed CHD diagnosis; of these, 70.2% (n = 167) had a fully correct CHD diagnosis in the NPR; a further 4.6% (n = 11) had a CHD diagnosis, but it was misclassified. MI diagnoses were validated in 167 (93.8%) patients with confirmed CHD. Of the patients with confirmed CHD, 88.0% (n = 147/167) had correct MI diagnoses. Patients with non-complex CHD diagnoses had more correct MI diagnoses than patients with complex CHD (91.0%, n = 131 compared with 69.6%, n = 16). The main cause for incorrect MI diagnoses was typographical error, contributing to 50.0% of the incorrect diagnoses. CONCLUSIONS: The validity of MI diagnoses in patients with confirmed CHD in the NPR is high, with nearly 9 of 10 MI diagnoses being correct (88.0%). MI in patients with CHD can safely be studied using the NPR.
format Online
Article
Text
id pubmed-7584083
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75840832020-10-26 Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden Fedchenko, Maria Mandalenakis, Zacharias Hultsberg-Olsson, Görel Dellborg, Helena Eriksson, Peter Dellborg, Mikael BMC Cardiovasc Disord Research Article BACKGROUND: The population of adults with congenital heart disease (CHD) is growing, and increasingly more patients with CHD reach older ages. Patients with CHD are at an increased risk of myocardial infarction (MI) with increased age. Diagnosing MI in patients with CHD can be challenging in clinical practice owing to a high prevalence of aberrant electrocardiograms, ventricular hypertrophy, and heart failure, among other factors. The National Swedish Patient Register (NPR) is widely used in epidemiological studies; however, MI diagnoses specifically in patients with CHD have never been validated in the NPR. METHODS: We contacted hospitals and medical archive services to request medical records for 249 patients, born during 1970–2012, with both CHD and MI diagnoses and who were randomly selected from the NPR by the Swedish National Board of Health and Welfare. Follow-up was until 2015. We performed a medical chart review to validate the MI diagnoses; we also validated CHD diagnoses to ensure that only patients with confirmed CHD diagnoses were included in the MI validation process. RESULTS: We received medical records for 96.4% (n = 238/249) of patients for validation of CHD diagnoses. In total, 74.8% (n = 178/238) had a confirmed CHD diagnosis; of these, 70.2% (n = 167) had a fully correct CHD diagnosis in the NPR; a further 4.6% (n = 11) had a CHD diagnosis, but it was misclassified. MI diagnoses were validated in 167 (93.8%) patients with confirmed CHD. Of the patients with confirmed CHD, 88.0% (n = 147/167) had correct MI diagnoses. Patients with non-complex CHD diagnoses had more correct MI diagnoses than patients with complex CHD (91.0%, n = 131 compared with 69.6%, n = 16). The main cause for incorrect MI diagnoses was typographical error, contributing to 50.0% of the incorrect diagnoses. CONCLUSIONS: The validity of MI diagnoses in patients with confirmed CHD in the NPR is high, with nearly 9 of 10 MI diagnoses being correct (88.0%). MI in patients with CHD can safely be studied using the NPR. BioMed Central 2020-10-23 /pmc/articles/PMC7584083/ /pubmed/33096985 http://dx.doi.org/10.1186/s12872-020-01737-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Fedchenko, Maria
Mandalenakis, Zacharias
Hultsberg-Olsson, Görel
Dellborg, Helena
Eriksson, Peter
Dellborg, Mikael
Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden
title Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden
title_full Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden
title_fullStr Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden
title_full_unstemmed Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden
title_short Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden
title_sort validation of myocardial infarction diagnosis in patients with congenital heart disease in sweden
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584083/
https://www.ncbi.nlm.nih.gov/pubmed/33096985
http://dx.doi.org/10.1186/s12872-020-01737-1
work_keys_str_mv AT fedchenkomaria validationofmyocardialinfarctiondiagnosisinpatientswithcongenitalheartdiseaseinsweden
AT mandalenakiszacharias validationofmyocardialinfarctiondiagnosisinpatientswithcongenitalheartdiseaseinsweden
AT hultsbergolssongorel validationofmyocardialinfarctiondiagnosisinpatientswithcongenitalheartdiseaseinsweden
AT dellborghelena validationofmyocardialinfarctiondiagnosisinpatientswithcongenitalheartdiseaseinsweden
AT erikssonpeter validationofmyocardialinfarctiondiagnosisinpatientswithcongenitalheartdiseaseinsweden
AT dellborgmikael validationofmyocardialinfarctiondiagnosisinpatientswithcongenitalheartdiseaseinsweden